Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Submitted by
admin
on July 28, 2010 - 10:22am
Source:
Bloomberg
News Tags:
Merck KGaA
multiple sclerosis
MS
cladribine
Novartis
Gilenia
Headline:
Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Do Not Allow Advertisers to Use My Personal information
